IFNG and neoplasm: Our results showed that anti-asialo GM1 antibody treatment reduced the α-GalCer-induced reduction of tumor growth (Additional file 1: Figure S3A), however, the anti-asialo GM1 mAb treatment did not affect the frequency of IFN-γ-producing NKT cells in the spleen (Additional file 1: Figure S3B).